September 2017
 << < > >>


Who's Online?

Member: 0
Visitor: 1

rss Syndication


02:00:19 pm

Health Net Expands Palliative Care In California & Oregon - Analyst Blog -

The palliative care program in Orange County has been launched in collaboration with Care Choices Hospice and Palliative Care Services. As for the programs in Oregon, Health Net has allied with Compass Oncology, and Hospice and Palliative Care Partners. According to World Health Organization, palliative care "is an approach that improves the quality of life of patients and their families facing the problem associated with life-threatening illness, through the prevention and relief of suffering by means of early identification and impeccable assessment and treatment of pain and other problems, physical, psychosocial and spiritual." Thus, it goes without saying that this approach is quite indispensable. This, in fact, is the primary reason that has made the Arizona Palliative Home Care so alex simring recommended reading successful. This program benefited patients by lowering emergency room visits and their stay in the hospital. This prompted Health Net to expand this specialized care program to other regions as well and hence the latest program expansion. Going ahead, such programs are not only expected to boost revenues of Health Net but also enhance its brand value in the health maintenance organization (HMO) space. Health Net holds a Zacks Rank #2 (Buy).
Health Net Expands Palliative Care in California & Oregon - Analyst Blog -

Health Care Sector Update for 03/11/2015: CAPN,MELA,ZGNX,PTX -

No analyst estimates were available for comparison. CAPN shares were up almost 25% at $6.91 shortly before today's closing bell, earlier climbing to a session high of $7.30 a share. The stock has traded between $1.02 to $9.90 a share since its Nov. 14 initial public offering of stock. In other sector news, (+) MELA, American Medical Association advisory panel last month accepts multi-spectral digital analysis of skin lesions by the company's MelaFind system, according to regulatory filing by the company today. (-) ZGNX, Confirms sale of its Zohydro pain-killer business to Pernix Therapeutics ( PTX ) for $100 mln plus additional regulatory and commercial milestone payments. Also, Q4 net loss of $0.13 per share is $0.02 wider than estimates. The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of The NASDAQ OMX Group, Inc.
Health Care Sector Update for 03/11/2015: CAPN,MELA,ZGNX,PTX -

Admin · 157 views · Leave a comment

Permanent link to full entry


No Comment for this post yet...

Leave a comment

New feedback status: Published

Your URL will be displayed.

Please enter the code written in the picture.

Comment text

   (Set cookies for name, e-mail and url)